metaLinear

metaLinear is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences.

metaLinear is a biotechnology company focused on identifying and validating new drug targets for difficult-to-treat bacterial infections. It uses protein-engineering-based technology to accelerate discovery and development of new classes of antibiotics.